
Subhendu Panigrahi
14K posts

Subhendu Panigrahi
@skipiit
2X Founder 1X Exit| Building @FOXOclub - Longevity Operating System for India |Co-Founder @OGclubDAO | Prev Co-Founder and CEO @skillenza EIR @BlumeVentures


I just upgraded my annual blood test with FOXO Primer and got more than I imagined. Because of an autoimmune issue, I’ve had to do more “understanding” of my blood tests than most people, who often look at ranges, underlines, and move on. My annual tests were already more than standard packages, and I had learned to understand inflammation trackers and other markers earlier than I would have liked :) But I knew there was more to know. The challenge was that going beyond standard or expanded tests was either too expensive, too fragmented, or missing the most important layer: someone looking at everything holistically and giving advice that worked across systems. Over the last few years, this has changed globally. Access to extensive biomarker testing has become easier, cheaper, and increasingly paired with medical professionals who know how to correlate results. FOXO brought this to India with FOXO Primer, a comprehensive 200+ biomarker assessment that combines clinical history, system-level analysis, and practical guidance to help you understand how your body is functioning and what you can do to improve it. I was genuinely impressed by the overall experience. We invested in FOXO at the founding stage because we had been clear on this opportunity for a while. But hearing founder Subhendu’s personal journey of “fixing his health”, the journey that led to FOXO, made the mission feel even more real. Nothing drives mission orientation like a personal story, and I could relate to his too. I believe the future of preventive healthcare will be driven by companies like FOXO: helping us understand our health earlier, act sooner, and hopefully avoid many reactive doctor visits later. Think of them as our future “pre-GPs.” Worth exploring if you’ve been curious but sitting on the sidelines: foxo.club/primer
















